Mablink Bioscience
FranceMablink Bioscience is a healthcare company, headquartered in France.
Entry
2022
Hold
1yr
Exit
2023
Est. EV
–
Who owns Mablink Bioscience?
Mablink Bioscience was owned by Sofinnova Partners through Sofinnova Capital X (2021 vintage) from 2022 to 2023, exited via Trade Sale. Across its history, Mablink Bioscience has been through 4 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Most recent investor
Sofinnova PartnersSofinnova Capital X · 2021 · Life Sciences VC
4 ownership periods · full history below
Key facts
HQFrance
SectorHealthcare
Key takeaways
- ·Fully exited in 2023.
- ·Average hold across 4 realized cycles: 2 years.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Exited
Last exited in 2023 to .
Co-invest · 4 holders · 2019 · 2023
Sofinnova PartnersExited 2023
2022 · 2023 · Sofinnova Capital X · 2021 · Life Sciences VC
Trade Sale · to
MOIC
–
MOIC
–
More from Sofinnova Capital X
Other portfolio companies in the same fund.
Germany
Denmark
Spain
UK
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
BelgiumData refreshed weekly · Sourced from public filings